REPORT ID 2913

Global Fibroblast Growth Factor Receptor 4 Market Research Report 2017

Publish Date
12-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the global Fibroblast Growth Factor Receptor 4 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Fibroblast Growth Factor Receptor 4 in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Fibroblast Growth Factor Receptor 4 market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Amgen Inc
    ArQule Inc
    AstraZeneca Plc
    Blueprint Medicines Corp
    Bristol-Myers Squibb Co
    Eisai Co Ltd
    Eli Lilly and Co
    Genosco Inc
    H3 Biomedicine Inc
    Incyte Corp
    Ionis Pharmaceuticals Inc
    Johnson & Johnson
    Merrimack Pharmaceuticals Inc
    NGM Biopharmaceuticals Inc
    Novartis AG
    Principia Biopharma Inc
    Tasly Pharmaceutical Group Co Ltd
    Vichem Chemie Research Ltd
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BLU-9931
    BMS-986036
    Erdafitinib
    ES-135
    FGF-401
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Breast Cancer
    Lymphoma
    Melanoma
    Fallopian Tube Cancer
    Lung Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Fibroblast Growth Factor Receptor 4 Market Research Report 2017
1 Fibroblast Growth Factor Receptor 4 Market Overview
    1.1 Product Overview and Scope of Fibroblast Growth Factor Receptor 4
    1.2 Fibroblast Growth Factor Receptor 4 Segment by Type (Product Category)
        1.2.1 Global Fibroblast Growth Factor Receptor 4 Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Fibroblast Growth Factor Receptor 4 Production Market Share by Type (Product Category) in 2016
        1.2.3 BLU-9931
        1.2.4 BMS-986036
        1.2.5 Erdafitinib
        1.2.6 ES-135
        1.2.7 FGF-401
        1.2.8 Others
    1.3 Global Fibroblast Growth Factor Receptor 4 Segment by Application
        1.3.1 Fibroblast Growth Factor Receptor 4 Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Breast Cancer
        1.3.3 Lymphoma
        1.3.4 Melanoma
        1.3.5 Fallopian Tube Cancer
        1.3.6 Lung Cancer
        1.3.7 Others
    1.4 Global Fibroblast Growth Factor Receptor 4 Market by Region (2012-2022)
        1.4.1 Global Fibroblast Growth Factor Receptor 4 Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Fibroblast Growth Factor Receptor 4 (2012-2022)
        1.5.1 Global Fibroblast Growth Factor Receptor 4 Revenue Status and Outlook (2012-2022)
        1.5.2 Global Fibroblast Growth Factor Receptor 4 Capacity, Production Status and Outlook (2012-2022)

2 Global Fibroblast Growth Factor Receptor 4 Market Competition by Manufacturers
    2.1 Global Fibroblast Growth Factor Receptor 4 Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Fibroblast Growth Factor Receptor 4 Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Fibroblast Growth Factor Receptor 4 Production and Share by Manufacturers (2012-2017)
    2.2 Global Fibroblast Growth Factor Receptor 4 Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Fibroblast Growth Factor Receptor 4 Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Fibroblast Growth Factor Receptor 4 Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Fibroblast Growth Factor Receptor 4 Market Competitive Situation and Trends
        2.5.1 Fibroblast Growth Factor Receptor 4 Market Concentration Rate
        2.5.2 Fibroblast Growth Factor Receptor 4 Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Fibroblast Growth Factor Receptor 4 Capacity and Market Share by Region (2012-2017)
    3.2 Global Fibroblast Growth Factor Receptor 4 Production and Market Share by Region (2012-2017)
    3.3 Global Fibroblast Growth Factor Receptor 4 Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Fibroblast Growth Factor Receptor 4 Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Fibroblast Growth Factor Receptor 4 Consumption by Region (2012-2017)
    4.2 North America Fibroblast Growth Factor Receptor 4 Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Fibroblast Growth Factor Receptor 4 Production, Consumption, Export, Import (2012-2017)
    4.4 China Fibroblast Growth Factor Receptor 4 Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Fibroblast Growth Factor Receptor 4 Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Fibroblast Growth Factor Receptor 4 Production, Consumption, Export, Import (2012-2017)
    4.7 India Fibroblast Growth Factor Receptor 4 Production, Consumption, Export, Import (2012-2017)

5 Global Fibroblast Growth Factor Receptor 4 Production, Revenue (Value), Price Trend by Type
    5.1 Global Fibroblast Growth Factor Receptor 4 Production and Market Share by Type (2012-2017)
    5.2 Global Fibroblast Growth Factor Receptor 4 Revenue and Market Share by Type (2012-2017)
    5.3 Global Fibroblast Growth Factor Receptor 4 Price by Type (2012-2017)
    5.4 Global Fibroblast Growth Factor Receptor 4 Production Growth by Type (2012-2017)

6 Global Fibroblast Growth Factor Receptor 4 Market Analysis by Application
    6.1 Global Fibroblast Growth Factor Receptor 4 Consumption and Market Share by Application (2012-2017)
    6.2 Global Fibroblast Growth Factor Receptor 4 Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Fibroblast Growth Factor Receptor 4 Manufacturers Profiles/Analysis
    7.1 Amgen Inc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Amgen Inc Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 ArQule Inc
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 ArQule Inc Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 AstraZeneca Plc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Blueprint Medicines Corp
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Bristol-Myers Squibb Co
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Eisai Co Ltd
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Eli Lilly and Co
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Genosco Inc
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Genosco Inc Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 H3 Biomedicine Inc
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Incyte Corp
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Fibroblast Growth Factor Receptor 4 Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Incyte Corp Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Ionis Pharmaceuticals Inc
    7.12 Johnson & Johnson
    7.13 Merrimack Pharmaceuticals Inc
    7.14 NGM Biopharmaceuticals Inc
    7.15 Novartis AG
    7.16 Principia Biopharma Inc
    7.17 Tasly Pharmaceutical Group Co Ltd
    7.18 Vichem Chemie Research Ltd

8 Fibroblast Growth Factor Receptor 4 Manufacturing Cost Analysis
    8.1 Fibroblast Growth Factor Receptor 4 Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Fibroblast Growth Factor Receptor 4

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Fibroblast Growth Factor Receptor 4 Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Fibroblast Growth Factor Receptor 4 Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Fibroblast Growth Factor Receptor 4 Market Forecast (2017-2022)
    12.1 Global Fibroblast Growth Factor Receptor 4 Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Fibroblast Growth Factor Receptor 4 Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Fibroblast Growth Factor Receptor 4 Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Fibroblast Growth Factor Receptor 4 Price and Trend Forecast (2017-2022)
    12.2 Global Fibroblast Growth Factor Receptor 4 Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Fibroblast Growth Factor Receptor 4 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Fibroblast Growth Factor Receptor 4 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Fibroblast Growth Factor Receptor 4 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Fibroblast Growth Factor Receptor 4 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Fibroblast Growth Factor Receptor 4 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Fibroblast Growth Factor Receptor 4 Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Fibroblast Growth Factor Receptor 4 Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Fibroblast Growth Factor Receptor 4 Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer